Sustained NF-κB activation and inhibition in β-cells have minimal effects on function and islet transplant outcomes

Area of Science:

• Endocrinology
• Immunology
• Molecular Biology

Background:

• Nuclear factor-kappa B (NF-κB) influences gene expression in pancreatic beta cells.
• The specific role of NF-κB activation in islet transplantation remains unclear.
• Understanding NF-κB's role is crucial for improving islet transplant success.

Purpose of the Study:

• To determine if NF-κB activation status affects islet transplantation outcomes.
• To investigate the impact of constitutive NF-κB activation and inhibition on transplanted islets.
• To evaluate the therapeutic potential of salicylate in modulating NF-κB for islet transplantation.

Main Methods:

• Generated transgenic mice with altered NF-κB signaling (constitutively active IKKβ or non-degradable IκBα) under the rat insulin promoter.
• Transplanted islets from these mice into streptozotocin-induced diabetic mice using suboptimal cell numbers.
• Administered salicylate to islets and recipient mice to assess its effects on NF-κB and transplantation outcomes.

Main Results:

• Islet transplantation outcomes were unaffected by islets with inhibited NF-κB (non-degradable IκBα).
• Islets with constitutively active NF-κB showed marginally worse transplantation outcomes, despite normal in vitro function.
• Salicylate treatment of islets or recipient mice did not alter transplantation success.

Conclusions:

• Pancreatic beta cells demonstrate adaptability to chronic NF-κB activation or inhibition, maintaining near-normal function.
• The study highlights the complex role of NF-κB in pancreatic beta cells and islet transplantation.
• Current NF-κB modulation strategies, like salicylate, do not significantly improve islet transplant outcomes in this model.